Finished product reference
Acetaminophen / Guaifenesin / Phenylephrine
Syrup · Oral · 125 mg/50 mg/2.5 mg/5mL · 60 mL
- List code
- 52665
- Pharmacologic class
- Combination cold preparation (analgesic-antipyretic, expectorant, decongestant)
What it is and how it works
Paracetamol relieves pain and fever; guaifenesin is an expectorant thought to increase the volume and reduce the viscosity of bronchial secretions; phenylephrine is an alpha-1 agonist nasal decongestant.
Indications
Short-term relief of cold and influenza symptoms with chesty, productive cough, nasal congestion, fever and aches.
Contraindications
Hypersensitivity to any component; severe hypertension or coronary disease; use with or within 14 days of MAO inhibitors; severe hepatic impairment; young children.
Warnings and precautions
Avoid other paracetamol-containing products. Use with caution in hypertension, hyperthyroidism, diabetes, cardiovascular disease, glaucoma and prostatic hypertrophy. Persistent cough beyond a week requires medical review.
Pregnancy
Generally avoided in pregnancy, particularly in the first trimester.
Storage and supply
Store below 25 °C, protected from light.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.